FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis
Detailed price information for Seastar Medical Hldg Corp (ICU-Q) from The Globe and Mail including charting and trades.
How Long Do Finasteride Results for Hair Growth Take?
Up until a couple of decades ago, hair loss was something that guys just had to accept and take in stride. Then came ...
Ocugen, Inc. (NASDAQ:OCGN) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 8, 2024 Operator: Good morning and welcome to Ocugen’s Third Quarter 2024 Financial ...
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 7, 2024 ClearPoint Neuro, Inc. misses on earnings expectations. Reported EPS is $-0.18 EPS, expectations were $-0.17. Operator: Greetings, and welcome to the ...
The Globe and Mail4h
SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE
The SCD-ADULT device has received FDA Breakthrough Device Designation for this indication ... the expected regulatory approval process and timeline for commercialization; and the ability of SeaStar ...
Where To Buy Steroids Online: A Look At Trusted Providers And Brands In The USA Market
Buying steroids in the USA requires careful attention to legality, quality, and source reliability. Opt for reputable brands ...
As AI Transforms Drug Development, FDA Is Scrambling to Figure Out Guardrails
Since 2016, the Food and Drug Administration has received about 300 drug submissions that reference artificial intelligence, ...
New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...